Laurus Bio has secured ₹120 crore in equity investment from Eight Roads Ventures and F-Prime Capital, with Laurus Labs co-investing ₹40 crore. This funding will expand Laurus Bio's fermentation-based manufacturing to meet growing demand for its animal-free proteins and growth factors used in various industries.
